Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:53 AM
Ignite Modification Date:
2025-12-25 @ 3:53 AM
NCT ID:
NCT05697302
Eligibility Criteria:
Inclusion Criteria:
* Can read and write Turkish and has no speech impediment,
* Being between the ages of 18-45 and having given birth for the first time,
* Mother and baby not having any health problems that would prevent breastfeeding (medications used in cancer treatment in the mother, some epilepsy medications, psychotherapy medications, migraine medications, Parkinson's medications, some painkillers, radioactive iodine use, active tuberculosis, HIV infection; congenital anomaly, galactosemia disease, phenylketonuria disease, congenital metabolic disease such as urea cycle enzyme defect),
* Not breastfeeding for at least 2 weeks and at most 8 weeks (for mothers who have never breastfed)
* Decreased milk supply that causes babies to be fed with formula for more than 2 weeks (for mothers with low milk supply),
* Having breastfeeding problems that cause decreased milk supply (breast refusal, incorrect breastfeeding techniques, breast abscess… starting work early…). •Separation of the baby or mother due to hospitalization, A mother who is formula feeding her baby changes her mind,
* No use of drugs that will affect the amount of milk (galactagogues such as metoclopramide, domperidone),
* The mother can be reached by phone,
* The baby is at least 15 days old and at most 4 months old.
Exclusion Criteria:
* Adopted/non-biological babies,
* Any health condition that would prevent breastfeeding or breastfeeding in the mother or baby (medications used in cancer treatment, some epilepsy medications, psychotherapeutic medications, migraine medications, Parkinson's medications, some painkillers, radioactive iodine use, active tuberculosis, HIV infection in the mother; congenital anomaly in the baby, galactosemia disease, phenylketonuria disease, congenital metabolic disease such as urea cycle enzyme defect), Use of medication that would affect milk quantity (galactagogues such as metoclopramide, domperidone)
* Women participating in another study on breastfeeding during the study period will not be included in the study.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
49 Years
Study:
NCT05697302
Study Brief:
Protocol Section:
NCT05697302